These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 25899606
1. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model. Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D. Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606 [Abstract] [Full Text] [Related]
7. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model. Lu HT, Zhao JG, Li MH, Li YD. Brain Res; 2012 Feb 15; 1438():75-84. PubMed ID: 22227456 [Abstract] [Full Text] [Related]
10. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats. Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y. Exp Neurol; 2015 Apr 15; 266():120-6. PubMed ID: 25708985 [Abstract] [Full Text] [Related]
11. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation. Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N. Eur J Neurosci; 2014 Jun 15; 39(12):2107-18. PubMed ID: 24649933 [Abstract] [Full Text] [Related]
12. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia. Liu W, Hendren J, Qin XJ, Liu KJ. Stroke; 2009 Jul 15; 40(7):2526-31. PubMed ID: 19478225 [Abstract] [Full Text] [Related]
13. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models. Krakovsky M, Polianski V, Nimrod A, Higazi A, Leker RR, Lamensdorf I. Neurol Res; 2011 Nov 15; 33(9):983-90. PubMed ID: 22081002 [Abstract] [Full Text] [Related]
17. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N. PLoS One; 2018 Nov 15; 13(5):e0198039. PubMed ID: 29795667 [Abstract] [Full Text] [Related]
18. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke. Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P. Stroke; 2013 Mar 15; 44(3):699-707. PubMed ID: 23422087 [Abstract] [Full Text] [Related]
19. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats. Tang J, Li YJ, Mu J, Li Q, Yang DY, Xie P. Neurol Res; 2009 Mar 15; 31(2):189-94. PubMed ID: 19298760 [Abstract] [Full Text] [Related]
20. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M. J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413 [Abstract] [Full Text] [Related] Page: [Next] [New Search]